Agarose soy casein digest medium for replacement of blood agar for potency determinations of live Pasteurella vaccines.
AUTOR(ES)
Rebers, P A
RESUMO
Blood agar, prepared with Trypticase (BBL Microbiology Systems, Cockeysville, Md.) soy agar and 5% defibrinated bovine blood, is used for testing the potency of live Pasteurella multocida and Pasteurella haemolytica vaccines, but its potential for variation makes it undesirable to use in a standard assay method. Tests done with RPMI 1640 and Trypticase soy medium indicated that the benefits obtained by adding defibrinated blood to the Trypticase soy agar medium were more likely due to neutralization of toxic components than to the presence of transferrin or iron as growth factors. Reduction of toxic components in the Trypticase soy agar medium was accomplished by replacing agar with agarose and by autoclaving glucose as a separate solution to produce the replacement medium. The replacement medium was prepared by autoclaving three separate solutions--Trypticase soy broth without glucose; glucose; and agarose--cooling to 55 degrees C, and mixing and then pouring the mixtures into petri dishes. The growth obtained with this medium as judged by determination of the number of CFU and the colony sizes of P. multocida or P. haemolytica was equal to or better than those obtained with blood agar.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=184062Documentos Relacionados
- Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.
- Attenuated Mengo virus: a new vector for live recombinant vaccines.
- Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines.
- Comparison of sodium alginate and oil adjuvants in Pasteurella multocida vaccines.
- Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.